We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IEX:NYSEIDEX Corporation Analysis

Data as of 2026-03-13 - not real-time

$188.13

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

IDEX Corp. (IEX) is trading around $188.13, comfortably above its 20‑day ($203.94) and 50‑day ($199.11) moving averages but still above the long‑term 200‑day average ($178.19), indicating a bullish bias despite a short‑term pullback. The stock sits near a technical support zone at $185.59 and shows an oversold RSI of 29 alongside a bearish MACD histogram, suggesting potential upside momentum toward the resistance level of $212.68. Recent earnings beat—Q4 revenue up 4.2% YoY to $899.1 M and non‑GAAP EPS of $2.10 surpassing consensus—has prompted an analyst upgrade to Buy and a consensus recommendation of Buy from 13 analysts, with median price targets around $230. The fundamentals are solid: forward PE of 20.94 (well below the trailing PE of 29.35 and the industry average of 29.19), a dividend yield of 1.51% with a payout ratio under 45%, and free cash flow of roughly $539 M supporting dividend sustainability. However, the DCF‑derived fair value of about $100 implies the market is pricing in a substantial premium, yielding an upside/downside metric of roughly +20% relative to the current price. In a sector characterized by moderate cyclicality and low regulatory scrutiny, IEX offers a blend of growth and value attributes but carries elevated valuation risk in the near term.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term price rebound
  • Support level at $185.59 providing a downside cushion
  • Recent earnings beat and analyst upgrade to Buy

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 20.94 suggesting attractive valuation relative to earnings growth
  • Sustainable dividend with a 44% payout ratio
  • Strong cash flow generation supporting capital allocation

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Current price far above DCF fair value indicating valuation risk
  • Stable market position in specialty industrial machinery
  • Consistent dividend and moderate growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin13.98%
P/E Ratio29.3
ROE12.34%
ROA6.63%
Debt/Equity48.25
P/B Ratio3.5
Op. Cash Flow$680.4M
Free Cash Flow$538.9M
Industry P/E29.2

Technical Analysis

TrendBullish
RSI29.3
Support$185.59
Resistance$212.68
MA 20$203.94
MA 50$199.11
MA 200$178.19
MACDBearish
VolumeDecreasing
Fear & Greed Index72.36

Valuation

Fair Value$100.10
Target Price$225.08
Upside/Downside19.64%
GradeOvervalued
TypeBlend
Dividend Yield1.51%

Risk Assessment

Beta0.89
Volatility27.14%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.